Insider · CIK 0001619795
Ronald G Forsythe Jr
Files at CPK (CHESAPEAKE UTILITIES CORP). First filing -, latest -.
Ronald G Forsythe Jr files SEC Form 4 as director at CPK (CHESAPEAKE UTILITIES CORP). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Ronald G Forsythe Jr has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 6, 2026 | CPK CHESAPEAKE UTILITIES CORP | AGrant or award Common Stock | +1,112 | $125.83 | $140k | 11,271 | May 8, 2026 |
| Jan 6, 2026 | CPK CHESAPEAKE UTILITIES CORP | FTax withholding Common Stock | -246 | $122.11 | $30k | 10,109 | Jan 8, 2026 |
| Jun 6, 2025 | CPK CHESAPEAKE UTILITIES CORP | FTax withholding Common Stock | -138 | $118.37 | $16k | 10,191 | Jun 10, 2025 |
| May 7, 2025 | CPK CHESAPEAKE UTILITIES CORP | AGrant or award Common Stock | +895 | $134.05 | $120k | 10,329 | May 9, 2025 |
Questions about Ronald G Forsythe Jr
Answered from the filings on this page, as of the latest one.
Is Ronald G Forsythe Jr buying or selling?
Ronald G Forsythe Jr has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Ronald G Forsythe Jr's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ronald G Forsythe Jr has 0.
Where does Ronald G Forsythe Jr file Form 4?
Ronald G Forsythe Jr has filed Form 4 at CPK (CHESAPEAKE UTILITIES CORP). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.